Recent Quotes (30 days)

You have no recent quotes
chg | %

Albemarle Corporation  

(Public, NYSE:ALB)   Watch this stock  
Find more results for ALB
140.78
+1.40 (1.00%)
Oct 20 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 140.06 - 141.29
52 week 76.32 - 141.30
Open 140.70
Vol / Avg. 925,475.00/1.37M
Mkt cap 15.55B
P/E 52.72
Div/yield 0.32/0.91
EPS 2.67
Shares 110.47M
Beta 1.66
Inst. own 88%
Nov 9, 2017
Q3 2017 Albemarle Corp Earnings Call - 9:00AM EST - Add to calendar
Nov 8, 2017
Q3 2017 Albemarle Corp Earnings Release - 4:00PM EST - Add to calendar
Sep 6, 2017
Albemarle Corp at UBS Global Chemicals & Paper and Packaging Conference
Aug 8, 2017
Q2 2017 Albemarle Corp Earnings Call - Webcast
Aug 7, 2017
Q2 2017 Albemarle Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 13.38% 15.65%
Operating margin 18.86% 21.46%
EBITD margin - 27.74%
Return on average assets 5.40% 4.72%
Return on average equity 11.20% 12.53%
Employees 5,000 -
CDP Score - -

Address

4350 Congress St Ste 700
CHARLOTTE, NC 28209-4865
United States - Map
+1-980-2995700 (Phone)
+1-225-3887686 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions. The bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Company serves various end markets, including petroleum refining, consumer electronics, energy storage, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services. As of December 31, 2016, the Company and its joint ventures operated 31 production and research and development (R&D) facilities, as well as a number of administrative and sales offices, around the world.

Officers and directors

Luther C. Kissam IV Chairman, President and Chief Executive Officer
Age: 52
Bio & Compensation  - Reuters
Scott A. Tozier Chief Financial Officer, Executive Vice President
Age: 51
Bio & Compensation  - Reuters
Karen G. Narwold Executive Vice President, Chief Administrative Officer
Age: 57
Bio & Compensation  - Reuters
Matthew K. Juneau Executive Vice President, Corporate Strategy
Age: 56
Bio & Compensation  - Reuters
Donald J. LaBauve Jr. Chief Accounting Officer, Vice President, Corporate Controller
Age: 50
Bio & Compensation  - Reuters
Jimmy W. Nokes Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
Laurie Brlas Director
Bio & Compensation  - Reuters
William H. Hernandez Independent Director
Age: 68
Bio & Compensation  - Reuters
Douglas L. Maine Independent Director
Age: 68
Bio & Compensation  - Reuters
Jerry Kent Masters Independent Director
Age: 57
Bio & Compensation  - Reuters